Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each of which is based on a different mRNA format. Now the companies are reporting that the most advanced candidate, BNT162b2, performed well in trials in which mice and macaques were infected with the coronavirus after inoculation. … more
Pfizer’s facility in Groton has a history of developing some of the most popular drugs ingested by Americans. But the pharmaceutical company’s work on a COVID-19 vaccine may give the Connecticut facility its greatest fame … more